Cardiac allograft vasculopathy (CAV) causes impaired blood flow in both epicardial vessels and microvasculature and remains a leading cause of posttransplant morbidity and mortality. This study ...

Journal of Nuclear Medicine January 2025, jnumed.124.267769; DOI: https://doi.org/10.2967/jnumed.124.267769 ...

Journal of Nuclear Medicine January 2025, jnumed.124.268578; DOI: https://doi.org/10.2967/jnumed.124.268578 ...

Journal of Nuclear Medicine January 2025, jnumed.124.268275; DOI: https://doi.org/10.2967/jnumed.124.268275 ...

Journal of Nuclear Medicine January 2025, jnumed.124.269268; DOI: https://doi.org/10.2967/jnumed.124.269268 ...

Journal of Nuclear Medicine January 2025, jnumed.124.268998; DOI: https://doi.org/10.2967/jnumed.124.268998 ...

Journal of Nuclear Medicine January 2025, jnumed.124.268233; DOI: https://doi.org/10.2967/jnumed.124.268233 ...

The Highlights Lecture, presented at the closing session of each SNMMI Annual Meeting, was originated and presented for more than 30 y by Henry N. Wagner, Jr., MD. Beginning in 2010, the duties of ...

Journal of Nuclear Medicine January 2025, jnumed.124.268861; DOI: https://doi.org/10.2967/jnumed.124.268861 ...

One important aspect of radiopharmaceutical therapy (RPT) that sets it apart from virtually all other oncologic therapeutic approaches is the ability to noninvasively image and verify the existence of ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...